Latest News

First ever phase 1 trial of genital chlamydia vaccine finds it is safe and provokes immune response

Chlamydia is the most common sexually transmitted bacterial infection worldwide, but national screening programmes and antibiotic treatment have failed to decrease infection incidences.

Source link

Related posts

Having more than one chronic disease amplifies costs of diseases, study finds


Study reveals structure of potential drug target in neurological conditions


Women Get Worse Paramedic Care In A Heart Attack


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy